11Jul/13

Janssen whizzes promising CLL agent over to regulators – Medical Marketing and Media

Janssen whizzes promising CLL agent over to regulators
Medical Marketing and Media
Gilead’s candidate, idelalisib, was tested in combination with rituximab in treatment-naïve patients with CLL. That regimen achieved a compete response rate of 19% and an overall response rate of 97% in patients. AbbVie’s contender, ABT-199, which Yee 

and more »

10Jul/13

Antibodies during pregnancy linked to autism – Futurity: Research News


Scientist

Antibodies during pregnancy linked to autism
Futurity: Research News
“The combination of brain and behavioral changes observed in the nonhuman primate offspring exposed to these autism-specific antibodies suggests that this is a very promising avenue of research,” says Melissa Bauman. (Credit: Joelle 
Researchers Identify Specific Fetal Antigens Attacked by Maternal AntibodiesScience Daily (press release)
Mother’s Antibodies May Explain a Quarter of Autism CasesTIME (blog)
Mom’s Antibodies May Cause Some AutismScience AAAS
MedPage Today –Scientist
all 30 news articles »